First Trust NYSE Arca Biotechnology Index Fund
156 hedge funds and large institutions have $719M invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 38 reducing their positions, and 19 closing their positions.
161% more call options, than puts
Call options by funds: $4.48M | Put options by funds: $1.72M
45% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 38
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
15% more capital invested
Capital invested by funds: $622M → $719M (+$96.3M)
1% more funds holding
Funds holding: 154 → 156 (+2)
0.5% more ownership
Funds ownership: 44.18% → 44.68% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$12.2M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.78M |
| 3 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
+$8.08M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$7.87M |
| 5 |
Morgan Stanley
New York
|
+$7.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
-$7.67M |
| 2 |
Goldman Sachs
New York
|
-$3.43M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.05M |
| 4 |
SAM
Silphium Asset Management
London,
United Kingdom
|
-$1.99M |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
-$1.2M |
FBT Hedge Fund Activity: Q2 2018 in Review
156 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2018, worth a combined $719M — up 15% from $622M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new FBT positions and 19 closed out — a net gain of 4 holders — while 55 added to existing stakes and 38 trimmed.
The largest buyer was Wells Fargo, adding an estimated $12.2M. The largest seller was Mariner Independent Advisor Network, cutting an estimated $7.67M.
- 156 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2018, up from 154 in Q1 2018.
- Funds reported $719M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2018, up 15% quarter-over-quarter.
- 23 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2018 and 19 closed out, a net change of +4 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2018 was Wells Fargo, an estimated $12.2M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2018 was Mariner Independent Advisor Network, an estimated $7.67M sold.
Based on aggregated 13F filings for Q2 2018.